Prognostic significance of platelet count in SLE patients

References

• Lam GKW, Petri M. Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 2005;23:S120–S132.
   PubMed Web of Science ®Google Scholar
• Ktona E, Barbullushi M, Backa T, Idrizi A, Shpata V, Roshi E. Evaluation of thrombocytopenia in systemic lupus erythematosus and correlation with different organs damages. Mater Sociomed 2014;26(2):122–124
   PubMedGoogle Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Jallouli M, Frigui M, Marzouk S, Snoussi M, Kechaou M, Kaddour N, Masmoudi H, Elloumi M and Bahloul Z. Clinical implications and prognostic significance of thrombocytopenia in Tunisian patients with systemic lupus erythematosus. Lupus 2012;21:682–687
   PubMed Web of Science ®Google Scholar
• Hepburn AL, Narat S, Mason JC. The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology 2010;49:2243–2254
   PubMed Web of Science ®Google Scholar
• Patel N, Mody GM. Acute presentation of thrombocytopaenia in systemic lupus erythematosus is associated with a high mortality in South Africa. Lupus 2014;23:204–212
   PubMed Web of Science ®Google Scholar
• Ziakas PD, Giannouli S, Zintzaras E, Tzioufas AG, Voulgarelis M. Lupus thrombocytopenia: clinical implications and prognostic significance. Ann Rheum Dis 2005;64:1366–9.
   PubMed Web of Science ®Google Scholar
• Karpatkin S. Autoimmune thrombocytopenic purpura. Semin Hematol 1985;22:260–288.
   PubMed Web of Science ®Google Scholar
• Mok CC, Lee KW, Ho CT, Lau CS, Wong RWS. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology 2000;39:399–406.
   PubMed Web of Science ®Google Scholar
• Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med 1991;80:605–612.
   PubMedGoogle Scholar
• Yehudai D, Toubi E, Shoenfeld Y, Vadasz Z. Autoimmunity and novel therapies in immune-mediated thrombocytopenia. Semin Hematol. 2013;50:S100–S108.
   Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3–40.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113(11):2386–93.
   PubMed Web of Science ®Google Scholar
• Cines DB, McMillan R. “Management of adult idiopathic thrombocytopenic purpura”. Annu Rev Med 2005;56:425–42.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288–291
   PubMed Web of Science ®Google Scholar
• Mosca M, Bombardieri S. Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol 2006;24 (Suppl. 43):S100–S104.
   Google Scholar
• Fernandez M, Alarcon GS, Apte M, Androde RM, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum 2007;56:614–621.
   PubMed Web of Science ®Google Scholar
• Ziakas PD, Poulou LS, Giannouli S, Tzioufas AG, Oulgarelis MV. Thrombocytopenia in lupus: baseline C3 as an independent risk factor for relapse. Ann Rheum Dis. 2007;66:130–13I.
   PubMed Web of Science ®Google Scholar
• Fossati G, Bucknall RC, Edwards SW. Fcgamma receptors in auto- immune diseases. Eur J Clin Invest 2001;31:821–831.
   PubMed Web of Science ®Google Scholar
• Ziakas PD, Routsias JG, Giannouli S, Tasidou A, Tzioufas AG, Voulgarelis M. Suspects in the tale of lupus-associated thrombocytopenia Clin Exp Immunol 2006;145:71–80.
   Google Scholar
• Aleem A, Saud Al Arfaj A, Khalil N, Alarfaj H. Haematological abnormalities in systemic lupus erythematosus Acta Reumatol Port. 2014;39:236–241
   PubMed Web of Science ®Google Scholar
• Arnal C, Piette JC, Leone J, Taillan B, Hachulla E, Roudot-Thoraval F, Papo T, Schaeffer A, Bierling P, Godeau B. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol 2002;29:75–83.
   PubMed Web of Science ®Google Scholar
• Boumpas DT, Barez S, Klippel JH, Balow JE. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med 1990;112:674–677.
   PubMed Web of Science ®Google Scholar
• Sultan SM, Begum S, Isenberg DA. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology (Oxford) 2003;42:230–234.
   PubMed Web of Science ®Google Scholar
• Ziakas PD. SLE Thrombocytopenia: from peripheral platelet destruction to central hemopoietic defect. Open Hematol J 2008;2:111–118
   Google Scholar
• Adly AA, Ragab IA, Ismail EA, Farahat MM. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia. Platelets, 2015;26(7):645–650.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li S, Yang R. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis. Platelets 2010;21:380–385
   PubMed Web of Science ®Google Scholar
• Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus: negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990;33:37–48
   PubMed Web of Science ®Google Scholar
• Kokori SI, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 2000;108:198–204.
   PubMed Web of Science ®Google Scholar
• Mestanza-Peralta M, Ariza-Ariza R, Cardiel MH, Alcocer-Varela J. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatol 1997;24:867–870.
   PubMed Web of Science ®Google Scholar